Paxlovid responsible for Biden testing positive for Covid again?

United States President Joe Biden has again tested positive for Covid-19 on Saturday, sending him back to isolation, though with mild symptoms. This is the second time that President Biden has tested positive for coronavirus infection. He had repeatedly tested negative last week for four days in a row, which is the period when he was on Paxlovid for the Covid-19 infection.

According to the White House doctor, the positive test result is a “rebound” post the Paxlovid treatment that he had received.

Chief Medical Officer to the President, Dr. Anthony Fauci too had experienced the “rebound positive” report due to Paxlovid as well. According to The Atlantic, “more than a third of Americans who have tested positive for COVID-19 this summer were treated with Paxlovid, and a large number of these tested back positive soon after testing negative”.

What is Paxlovid and Paxlovid rebound?

Paxlovid is an oral antiviral drug developed by Pfizer pharma giant. According to The Atlantic, Paxlovid has been proved to reduce the risk of hospitalization and death by 89 per cent. This year in January, President Biden had called the drug “a real game changer”. The drug is made up of two protease inhibitors, including one which is used to treat HIV infection as a booster medicine.

Past few months have recorded a surge in medical practitioners in US prescribing Paxlovid as part of Covid treatment regime. Many patients have reported side effects including a bitter, metallic taste among others. Furthermore, when the course of drug was over, the patients went back testing positive for Covid-19, phenomenon came to be known as “Paxlovid rebound”. The CDC defined rebound cases as “characterized by a recurrence of covid-19 symptoms or a new positive viral test after having tested negative.”

But the prevalence of rebound is fairly low. “When you look at the studies, it generally does not occur very often,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and President Joe Biden’s chief medical adviser.

Rashmi Sacher

Recent Posts

Why the 2025 Flu Season in the UK Started Earlier Than Usual — and What It Means for Your H3N2 Vaccine Timing

The UK is experiencing a relatively early onset of the 2025 flu season, and this has caused anxiety in terms… Read More

December 6, 2025

K-Pop’s Influence on Global Sneakers: How Vans’ Fantasy Collabs Are Changing Fashion Trends

K-pop is not only ruling the world music charts, but the genre is also redefining the fashion trends from head… Read More

December 6, 2025

Rise of Digital Detox Cabins Across Europe: Why Screen-Free Retreats Are Becoming a Travel Trend

Due to the rise in the tech-driven nature of Europe, there is an increasing number of individuals yearning to get… Read More

December 6, 2025

IndiGo Flight-Cancellation Chaos in India: Impacts on Travel and Transport

Thousands of passengers have been stranded, and the impact of mass flight cancellations by IndiGo in India has brought extensive… Read More

December 6, 2025

U.S. Executive Action Against a Transnational Extremist Network Framed as a Global Security Priority

The recent U.S. Executive Order against a transnational extremist network is gaining a growing international movement that is backing the… Read More

December 6, 2025

Sustainable Weight Loss vs “Quick Fix” Meds: Routines, Food Habits, and Realistic Results

Sustainable weight loss is built on consistent habits, not miracle pills or overnight transformations. Instead of addressing the underlying causes… Read More

December 6, 2025

This website uses cookies.

Read More